We use cookies to understand how visitors search for and consume the information we provide, so that we can improve their experience. By browsing this website, you indicate your acceptance of the use of such cookiesAcceptRead more

Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Our products& pipeline
    • Diseases we target
    • GS010 for LHON
    • GS030 for Retinitis Pigmentosa
    • GS030 for Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
  • Investors& media
    • Company Overview
    • Press releases
    • Events & presentations
    • Stock information
    • Governance
    • Documentation

Events & presentations

16 Jun 2019 - 19 Jun 2019

14th Meeting of EUNOS, Porto, Portugal

13 Jun 2019 - 16 Jun 2019

2019 SOE Congress, European Society of Ophthalmology, Nice, France

03 Jun 2019 - 06 Jun 2019

BIO International Convention, Philadelphia, PA (US)

23 May 2019

KOL Event to present Phase 3 REVERSE&RESCUE results of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON), New York City

28 Apr 2019 - 02 May 2019

ARVO Annual Meeting, Vancouver, BC, Canada

25 Mar 2019 - 27 Mar 2019

BioEurope Spring, Vienna, Austria

22 Mar 2019 - 24 Mar 2019

Sonoma Eye 2019, Sonoma, CA

16 Mar 2019 - 21 Mar 2019

45th NANOS Annual Meeting, Las Vegas, Nevada, US

01 Mar 2019 - 02 Mar 2019

9th EURETINA Winter Meeting, Prague, Czech Republic

10 Jan 2019 - 11 Jan 2019

Oddo BHF Forum, Lyon, France

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 10
  • View next 9 articles
© 2019 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
Go back to the page of the page